Julien Amat, PhD
Postdoctoral AssociateDownloadHi-Res Photo
About
Titles
Postdoctoral Associate
Appointments
Laboratory Medicine
Postdoctoral AssociatePrimary
Other Departments & Organizations
Education & Training
- PhD
- University of Glasgow, Centre For Virus Research (2022)
Research
Overview
Medical Subject Headings (MeSH)
Coinfection; Cytokines; Influenza, Human; Influenzavirus A; Organoids; Pneumonia, Viral; Respiratory Syncytial Viruses; Respiratory Tract Infections; Rhinovirus; SARS-CoV-2; Viral Zoonoses; Virus Diseases; Viruses
Research at a Glance
Yale Co-Authors
Frequent collaborators of Julien Amat's published research.
Research Interests
Research topics Julien Amat is interested in exploring.
Ellen F Foxman, MD, PhD
Marie-Louise Landry, MD
Timothy Watkins
Wade Schulz, MD, PhD
Cytokines
Coinfection
SARS-CoV-2
Publications
2024
High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children
Watkins T, Green A, Amat J, Cheemarla N, Hänsel K, Lozano R, Dudgeon S, Germain G, Landry M, Schulz W, Foxman E. High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children. Journal Of Experimental Medicine 2024, 221: e20230911. PMID: 38949638, PMCID: PMC11215523, DOI: 10.1084/jem.20230911.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBacterial pathobiontsRespiratory virusesBurden of virusesSARS-CoV-2Innate immune activationSARS-CoV-2 viral loadDynamic host-pathogen interactionsInnate immune responseViral coinfectionCytokine profileViral loadNasal virusImmune activationProinflammatory responseIL-1BNasopharyngeal samplesHost-pathogen interactionsImmune responseInterferon responsePathobiontsInnate immunityPaired samplesCXCL10Healthy 1-year-oldVirus
2022
SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity.
Manali M, Bissett LA, Amat JAR, Logan N, Scott S, Hughes EC, Harvey WT, Orton R, Thomson EC, Gunson RN, Viana M, Willett B, Murcia PR. SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity. The Journal Of Infectious Diseases 2022 PMID: 35920058, PMCID: PMC9384671, DOI: 10.1093/infdis/jiac332.Peer-Reviewed Original Research
2021
Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology.
Dee K, Goldfarb DM, Haney J, Amat JAR, Herder V, Stewart M, Szemiel AM, Baguelin M, Murcia PR. Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology. The Journal Of Infectious Diseases 2021, 224: 31-38. PMID: 33754149, PMCID: PMC8083659, DOI: 10.1093/infdis/jiab147.Peer-Reviewed Original ResearchSevere Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting.
Hughes EC, Amat JAR, Haney J, Parr YA, Logan N, Palmateer N, Nickbakhsh S, Ho A, Cherepanov P, Rosa A, McAuley A, Broos A, Herbert I, Arthur U, Szemiel AM, Roustan C, Dickson E, Gunson RN, Viana M, Willett BJ, Murcia PR. Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting. The Journal Of Infectious Diseases 2021, 223: 971-980. PMID: 33367847, PMCID: PMC7798933, DOI: 10.1093/infdis/jiaa788.Peer-Reviewed Original Research
Links & Media
Get In Touch
Contacts
Email